AI assistant
Sending…
DEXCOM INC — Director's Dealing 2016
Dec 19, 2016
30198_dirs_2016-12-19_105fc156-ec3b-480d-a811-40fbae05af78.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-12-15
Reporting Person: GREGG TERRANCE H (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-12-15 | Common Stock | G | 10000 | $0.0 | Disposed | 55882 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 442777 | Direct |
| Common Stock | 11461 | Indirect |
Footnotes
F1: This transaction represents a gift of securities made by the reporting person to a donor-advised fund. This is not a market transaction, thus no price has been reported. Transferor retains no beneficial or voting interest in the transferred shares.
F2: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17